Treatment of Liver Diseases With Cell Death Inducing DFFA Like Effector B (CIDEB) Inhibitors
US-2024376471-A1 · Nov 14, 2024 · US
Diagnosis and treatment of cancer
US9040286B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9040286-B2 |
| Application number | US-201013147713-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 3, 2010 |
| Priority date | Feb 3, 2009 |
| Publication date | May 26, 2015 |
| Grant date | May 26, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided herein are methods for diagnosing cancer by determining the level of expression of SETDB1 in a biological sample. Also provided herein are methods for treating cancer by administering an inhibitor of SETDB1 to a subject in need thereof.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for facilitating the diagnosis of lung cancer or melanoma in a subject, the method comprising: selecting a subject having at least one solid tumor or growth or a nevus; measuring the level of SETDB1 in a biological sample obtained from the subject who has at least one solid tumor or growth or a nevus, wherein the biological sample is derived from the at least one solid tumor or growth or nevus from the subject wherein the level of SETDB1 is…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
- C12N15/1137Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Physics · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9040286B2 cover?
- Provided herein are methods for diagnosing cancer by determining the level of expression of SETDB1 in a biological sample. Also provided herein are methods for treating cancer by administering an inhibitor of SETDB1 to a subject in need thereof.
- Who is the assignee on this patent?
- Zon Leonard I, Ceol Craig, Houvras Yariv J, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification C12N15/1137. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).